臨床外科68巻6号

2013年06月発行

特集 胃癌腹膜転移治療の最前線

胃癌腹膜転移に対する術中腹腔内温熱化学療法（HIPEC）の歴史と現況

著者： 片山寛次¹

所属機関： ¹福井大学医学部附属病院がん診療推進センター

ページ範囲：P.680 - P.688

文献概要

【ポイント】

◆胃癌の腹膜転移に対するHIPECはわが国で始まったが，合併症頻度の割に効果が得られず，施行施設は減少した．

◆欧米では，大腸癌，腹膜偽粘液腫の治療としてHIPECは標準治療であり，胃癌の腹膜転移にも応用され始めた．

◆胃癌では，術前化学療法有効例に可及的な減量手術とHIPEC併用が勧められるが，経験豊富な施設で行うべきである．

参考文献

1）Shiu MH, Fortner JG：Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res 40：4081-4084, 1980

2）Spratt JS, Adcock RA, Sherrill W, et al：Hyperthermic peritoneal perfusion system in canines. Cancer Res 40：253-255, 1980

3）Spratt JS, Adcock RA, Muskovin M, et al：Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40：256-260, 1980

4）古賀成昌，清水法男，前田迪郎，他：癌（主として消化器癌）に対する温熱化学療法．癌と化療10：358-365，1983

5）Kunisaki C, Shimada H, Nomura M, et al：Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 131：521-528, 2002

6）Cotte E, Passot G, Gilly FN, et al：Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2：31-35, 2010

7）Katayama K, Note M, Fujita H, et al：Continuous Hyperthermic Peritoneal Perfusion Using Peritoneal Cavity Expander. Hyperthermic Oncology 1：450-451, 1988

8）片山寛次，村上　真，廣野靖夫，他：スキルス胃癌に対する温熱化学療法―安全かつ効果的なCHPPの手技．臨外61：755-762，2006

9）Thomas F, Ferron G, Gesson-Paute A, et al：Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy（HIPEC）. Ann Surg Oncol 15：3623-3624, 2008

10）片山寛次，中川原儀三：胃癌腹膜転移に対するCHPP―安全かつ効果的な治療法の検討．宮崎逸夫，米村　豊（編）：進行胃癌に対する治療戦略．ソフトサイエンス社，1995, pp 162-169

11）Sugarbaker PH：Management of Peritoneal Surface Malignancy Using Intraperitoneal Chemotherapy and Cytoreductive Surgery：a Manual for Physician and Nurses, 3rd ed. Grand Rapids, Michigan, The Ludann Company, 1998

12）藤村　隆，米村　豊，野島直巳，他：Borrmann 4型胃癌に対する手術療法および持続温熱腹膜灌流法の治療効果．日消外会誌28：639-644，1995

13）Perez CA, Sapareto SA：Thermal dose expression in clinical hyperthermia and correlation with tumor response/control. Cancer Res：44：4818s-4825s, 1984

14）Sano T：Is peritoneal carcinomatosis an incurable disease or controllable locoregional condition?―Challenge of surgeons with intraperitoneal hyperthermic chemotherapy. Jpn J Clin Oncol 31：571-572, 2001

15）米村　豊（編）：腹膜播種．へるす出版，1996

16）Los G, van Vugt MJ, Pinedo HM：Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 69：235-241, 1994

17）Yonemura Y, Elnemr A, Endou Y, et al：Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2：85-97, 2010

18）Koga S, Hamazoe R, Maeta M, et al：Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61：232-237, 1988

19）古賀成昌，前田廸郎：胃癌腹膜播種に対する温熱化学療法．消外6：1189-1194，1983

20）Fujimura T, Yonemura Y, Muraoka K, et al：Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer：randomized controlled study. World J Surg 18：150-155, 1994

21）Gilly FN, Carry PY, Sayag AC, et al：Regional chemotherapy（with mitomycin C）and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41：124-129, 1994

22）Fujimoto S, Shrestha RD, Kokubun M, et al：Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208：36-41, 1988

23）Fujimoto S, Takahashi M, Mutou T, et al：Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer. Cancer Treat Res 81：169-176, 1996

24）Yonemura Y, Fujimura T, Fushida S, et al：Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 15：530-535, 1991

25）Katayama K, Makimoto K, Maeda H, et al：Continuous Hyperthermic Peritoneal Perfusion（CHPP）―Thermal dose during CHPP and response to treatment. Hyperthermic Oncology in Japan'97, 1997, pp 50-53

26）Glehen O, Gilly FN, Arvieux C, et al：Peritoneal carcinomatosis from gastric cancer：a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17：2370-2377, 2010

27）Yang XJ, Huang CQ, Suo T, et al：Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer：final results of a phase III randomized clinical trial. Ann Surg Oncol 18：1575-1581, 2011

28）Yan, TD, Black D, Sugarbaker PH, et al：A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14：2702-2713, 2007

29）Gill RS, Al-Adra DP, Nagendran J, et al：Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC：a systematic review of survival, mortality, and morbidity. J Surg Oncol 104：692-698, 2011

30）Kerkar SP, Kemp CD, Duffy A, et al：The GYMSSA trial：a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials 10：121, 2009

31）Fujimura T, Yonemura Y, Fushida S, et al：Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 65：65-71, 1990

32）Yonemura Y, Fujimura T, Fushida S, et al：A new surgical approach（peritonectomy）for the treatment of peritoneal dissemination. Hepatogastroenterology：46：601-609, 1999

33）Hirose K, Katayama K, Iida A, et al：Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer：evaluation by multivariate regression analysis. Oncology 57：106-114, 1999

34）大久保賢治：胃癌に対する持続温熱腹膜灌流療法の効果．日消外会誌32：1142-1151，1999

35）米村　豊，川村泰一，板東悦郎，他：腹膜播種を有する胃癌に対する術前全身化学療法・腹腔内化学療法を組み合わせた集学的治療の効果．がんと化療31：1723-1726，2004

36）古賀成昌：胃癌腹膜転移に対する集学的治療．癌の臨31：1103-1105，1985

37）Koga S, Hamazoe R, Maeta M, et al：Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61：232-237, 1988

38）Hamazoe R, Maeta M, Kaibara N：Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer：final results of a randomized controlled study. Cancer 73：2048-2052, 1994

39）Yonemura Y, Ninomiya I, Kaji M, et al：Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 19：450-454, 1995

40）Ikeguchi M, Kondou A, Oka A, et al：Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 161：581-586, 1995

41）Yonemura Y, de Aretxabala X, Fujimura T, et al：Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer：final results of a randomized controlled study. Hepatogastroenterology 48：1776-1782, 2001

42）Mizumoto A, Canbay E, Hirano M, et al：Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterol Res Pract, 2012〔Published online 2012 June 18〕

43）Yonemura Y, Endou Y, Sasaki T, et al：Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol 36：1131-1138, 2010